Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I

Journal of Gastroenterology

Volumn 51, Issue 6, 2016, Pages 571-578

  Nishida, Toshirou ^a,b   Tsujimoto, Masahiko ^a   Takahashi, Tsuyoshi ^c   Hirota, Seiichi ^d   Blay, Jean Yves ^e   Wataya Kaneda, Mari ^c  

^a OSAKA POLICE HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e CENTRE LÉON BÉRARD   (France)

Author keywords

Clinicopathologic features; Gastrointestinal stromal tumor; Neurofibromatosis type I; Prognosis

Indexed keywords

CONTRAST MEDIUM;

ADRENAL TUMOR; ADULT; AGED; ANEMIA; ARTICLE; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; DISEASE COURSE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; INTERSTITIAL CELL OF CAJAL; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; MIDDLE AGED; MITOSIS RATE; MORTALITY; MULTICENTER STUDY (TOPIC); MULTIDETECTOR COMPUTED TOMOGRAPHY; MUTATIONAL ANALYSIS; NEUROFIBROMATOSIS TYPE 1; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; UTERUS MYOMA; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; DIAGNOSTIC IMAGING; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; JAPAN; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUROFIBROMATOSIS 1; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84945561012     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-015-1132-6     Document Type: Article

References (25)

1. Corless CL, Barnett CM, Heinrich MC. Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer. 2011;11:865–78.
2. Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013;382:973–8.
3. Brems H, Beert E, de Ravel T, Legius E. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 2009;10:508–15.
4. Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81–8.
5. Brasfield RD. Das Gupta TK. von Recklinghausen’s disease: a clinicopathological study. Ann Surg. 1972;175:86–104.
6. Cheng SP, Huang MJ, Yang TL, et al. Neurofibromatosis with gastrointestinal stromal tumors: insights into the association. Dig Dis Sci. 2004;49:1165–9.
7. Takazawa Y, Sakurai S, Sakuma Y, et al. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen’s disease). Am J Surg Pathol. 2005;29:755–63.
8. Miettinen M, Fetsch JF, Sobin LH, et al. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol. 2006;30:90–6.
9. Lee JL, Kim JY, Ryu MH, et al. Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1. Dig Dis Sci. 2006;51:1043–6.
10. Mussi C, Schildhaus HU, Gronchi A, et al. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Clin Cancer Res. 2008;14:4550–5.
11. Zöller ME, Rembeck B, Odén A, et al. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer. 1997;79:2125–31.
12. Kinoshita K, Hirota S, Isozaki K, et al. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol. 2004;202:80–5.
13. Yantiss RK, Rosenberg AE, Sarran L, et al. Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study. Mod Pathol. 2005;18:475–84.
14. Andersson J, Sihto H, Meis-Kindblom JM, et al. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol. 2005;29:1170–6.
15. Maertens O, Prenen H, Debiec-Rychter M, et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet. 2006;15:1015–23.
16. Nishida T, Kumano S, Sugiura T, et al. Multidetector CT of high-risk patients with occult gastrointestinal stromal tumors. Am J Roentogenol. 2003;180:185–9.
17. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577–80.
18. Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 2001;61:8118–21.
19. Hirota S, Ohashi A, Nishida T, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology. 2003;125:660–7.
20. Ghrist TD. Gastrointestinal involvement in neurofibromatosis. Arch Intern Med. 1963;112:357–62.
21. Jang KM, Min K, Kim MJ, et al. Diagnostic performance of CT in the detection of intestinal ischemia associated with small-bowel obstruction using maximal attenuation of region of interest. AJR Am J Roentgenol. 2010;194:957–63.
22. Yamamoto H, Tobo T, Nakamori M, et al. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q. J Cancer Res Clin Oncol. 2009;135:791–8.
23. Chi P, Chen Y, Zhang L, et al. ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. Nature. 2010;467:849–53.
24. Nishida T, Hirota S, Taniguchi M, et al. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet. 1998;19:323–4.
25. Chen H, Hirota S, Isozaki K, et al. Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours. Gut. 2002;51:793–6.